• Home
  • Finance
  • Sabra Health Care REIT, Inc. (NASDAQ: SBRA) Received Consensus Recommendation to “Hold” by Brokerages

Sabra Health Care REIT, Inc. (NASDAQ: SBRA) Received Consensus Recommendation to “Hold” by Brokerages

By on June 3, 2022 0

Sabra Health Care REIT, Inc. (NASDAQ: SBRA – Get a rating) was awarded a consensus recommendation of “Hold” from the eleven research firms that currently cover the business, MarketBeat reports. Six investment analysts rated the stock with a hold recommendation and five gave the company a buy recommendation. The 1-year average target price among brokers who have reported on the stock in the past year is $16.13.

A number of equity research analysts have weighed in on the company recently. StockNews.com supposed coverage on Sabra Health Care REIT in a Thursday, March 31, research note. They issued a “hold” rating for the company. Barclays cut Sabra Health Care REIT from an “overweight” rating to an “equal weight” rating and lowered its price target for the company from $16.00 to $14.00 in a Monday, April 18 research note . Stifel Nicolaus lowered his price target on Sabra Health Care REIT from $21.00 to $18.00 and set a “buy” rating for the company in a Wednesday, February 23 research note. Mizuho upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and lowered its price target for the company from $16.00 to $15.00 in a Wednesday, May 25 research note. Finally, JMP Securities lowered its price target on Sabra Health Care REIT from $20.00 to $16.00 and set a “buy” rating for the company in a Tuesday, February 15 research note.

(A d)

The White House is worried that our country’s lithium supply is running out. That’s why Biden issued Executive Order 14017 to determine how to expand our lithium production. And that’s GREAT news for a company gobbling up land in Nevada’s lithium-rich desert.

SBRA stock opened at $13.82 on Friday. The company has a fifty-day moving average of $13.29 and a two-hundred-day moving average of $13.46. The company has a quick ratio of 3.60, a current ratio of 3.60 and a leverage ratio of 0.70. The stock has a market capitalization of $3.19 billion, a price-earnings ratio of -28.20 and a beta of 1.41. Sabra Health Care REIT has a 52-week low of $11.44 and a 52-week high of $19.01.

Sabra Health Care REIT (NASDAQ: SBRA – Get a rating) last reported results on Wednesday, May 4. The real estate investment trust reported earnings per share (EPS) of $0.18 for the quarter, beating the consensus estimate of $0.17 by $0.01. Sabra Health Care REIT posted a negative return on equity of 3.15% and a negative net margin of 18.28%. In the same quarter a year earlier, the company had earned earnings per share of $0.39. As a group, sell-side analysts expect Sabra Health Care REIT to post 1.5 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, May 31. Shareholders of record on Monday, May 16 received a dividend of $0.30 per share. This represents a dividend of $1.20 on an annualized basis and a yield of 8.68%. The ex-dividend date was Friday, May 13. Sabra Health Care REIT’s dividend payout ratio (DPR) is -244.89%.

Hedge funds and other institutional investors have recently changed their positions in the company. Mirae Asset Global Investments Co. Ltd. increased its holdings of Sabra Health Care REIT shares by 6.1% in Q1. Mirae Asset Global Investments Co. Ltd. now owns 27,827 shares of the real estate investment trust valued at $414,000 after purchasing an additional 1,602 shares in the last quarter. Keeley Teton Advisors LLC increased its stake in Sabra Health Care REIT by 13.3% during Q1. Keeley Teton Advisors LLC now owns 591,526 shares of the real estate investment trust worth $8,808,000 after acquiring an additional 69,361 shares in the last quarter. Weiss Multi Strategy Advisers LLC increased its stake in Sabra Health Care REIT by 230.8% in Q1. Weiss Multi Strategy Advisers LLC now owns 992,410 shares of the real estate investment trust worth $14,777,000 after acquiring an additional 692,438 shares in the last quarter. Advisors Asset Management Inc. increased its stake in Sabra Health Care REIT by 34.2% during the 1st quarter. Advisors Asset Management Inc. now owns 153,741 shares of the real estate investment trust worth $2,289,000 after acquiring 39,170 additional shares in the last quarter. Finally, Jane Street Group LLC increased its stake in Sabra Health Care REIT by 604.1% during the 1st quarter. Jane Street Group LLC now owns 495,994 shares of the real estate investment trust valued at $7,385,000 after acquiring an additional 425,549 shares in the last quarter. 91.61% of the shares are held by institutional investors.

About Sabra Health Care REIT (Get a rating)

As of September 30, 2020, Sabra’s investment portfolio comprised 425 properties held for investment (including (i) 287 skilled nursing/transitional care facilities, (ii) 64 Senior Housing – Leased), (iii) 47 Senior Residences operated by third-party property managers under property management contracts (Senior Housing – Managed) and (iv) 27 Specialized Hospitals and Other Establishments), an asset held for sale , one investment in direct leasing, 19 investments in loans receivable (including (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six investments in preferred shares and one investment in an unconsolidated joint venture that owns 158 seniors housing – managed communities.

Featured Articles

Analyst Recommendations for Sabra Health Care REIT (NASDAQ: SBRA)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Should you invest $1,000 in Sabra Health Care REIT right now?

Before you consider Sabra Health Care REIT, you’ll want to hear this.

MarketBeat tracks Wall Street’s top-rated, top-performing research analysts daily and the stocks they recommend to their clients. MarketBeat identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market goes higher…and Sabra Health Care REIT was not on the list.

While Sabra Health Care REIT currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the 5 actions here

  Finance